<?xml version="1.0" encoding="UTF-8"?>
<p id="para0032">There is no dosage adjustments available for chloroquine in patients with renal failure from the manufacture's labeling but according to UpToDate some clinicians use the following guideline 
 <sup>52</sup>:
 <list list-type="simple" id="celist0006">
  <list-item id="celistitem0009">
   <label>A)</label>
   <p id="para0033">Patients with GFR â‰¥ 10 ml/min: No dosage adjustment is required.</p>
  </list-item>
  <list-item id="celistitem0010">
   <label>B)</label>
   <p id="para0034">Patients with GFR &lt; 10 ml/min: Dosage should be reduced to 50%.</p>
  </list-item>
  <list-item id="celistitem0011">
   <label>C)</label>
   <p id="para0035">Patients with peritoneal- or hemodialysis: Dosage should be reduced to 50%.</p>
  </list-item>
  <list-item id="celistitem0012">
   <label>D)</label>
   <p id="para0036">Patients with continuous renal replacement therapy (CRRT): No dosage adjustment is required.</p>
  </list-item>
 </list>
</p>
